Pfizer Inc is to close its Neusentis research centre in Cambridge, UK where about 120 researchers carry out work on pain, sensory disorders, and regenerative medicine, the company confirmed in a statement on 3 December. ---Subscribe to MedNous to access this article--- Company News
